Potent and selective GPR39 agonist (EC50 values are 0.4 and 0.8 nM for rat and human receptors respectively). Selective over a panel of kinases (IC50s > 10 μM) and displays minimal binding affinity for ghrelin and neurotensin-1 receptors (IC50s > 30 μM). Increases GLP-1 levels in vitro and in vivo. Orally bioavailable.
|Storage||Store at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 418.9. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.39 mL||11.94 mL||23.87 mL|
|5 mM||0.48 mL||2.39 mL||4.77 mL|
|10 mM||0.24 mL||1.19 mL||2.39 mL|
|50 mM||0.05 mL||0.24 mL||0.48 mL|
References are publications that support the products' biological activity.
Peukert et al (2014) Discovery of 2-pyridylpyrimidines as the first orally bioavailable GPR39 agonists. ACS Med.Chem.Lett. 5 1114 PMID: 25313322
If you know of a relevant reference for TC-G 1008, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: TC-G 1008, supplier, TC-G1008, potent, selective, GPR39, agonists, agonism, Orphan, 7-TM, Receptors, Orphan, 7-TM, Receptors, Tocris Bioscience
1 Citation for TC-G 1008
Citations are publications that use Tocris products. Selected citations for TC-G 1008 include:
Mlyniec et al (2016) Potential antidepressant-like properties of the TC G-1008, a GPR39 (zinc receptor) agonist. J Affect Disord. 201 179 PMID: 27235821
Do you know of a great paper that uses TC-G 1008 from Tocris? If so please let us know.
TC-G 1008 Reviews
Average Rating:(Based on 0 Reviews)